🔗 Permalink

Inventor profile of:

Gary D. Glick

City:

Ann Arbor, Michigan

Country:

United States

Published Applications:

Last publication date:

2024-03-07

Top Assignees for applications by Gary D. Glick

The entities that hold a legal rights for patent applications filed by inventor Glick Gary D.:

THE REGENTS OF THE UNIVERSITY OF MICHIGAN 32 Ann Arbor, MI United States
First Wave Bio, Inc. 10 Ann Arbor, MI United States
Regents of the University of Michigan 8 Ann Arbor, MI United States
Lycera Corporation 7 Ann Arbor, MI United States
INNATE TUMOR IMMUNITY, INC. 5 Princeton, NJ United States
IFM THERAPEUTICS, INC 1 Cambridge, MA United States
Merck Sharp Dohme Corp. 1 Rahway, NJ United States
Lycera Corporation 1 Ann Arbor, MA United States
The Regents of the University of Michigan 1 Arbor, MI United States

Recent patent applications by Glick Gary D.

Gary D. Glick from Ann Arbor, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-07

US20240074995A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES

#2 | 2024-02-29

US20240067649A1

Chemistry; metallurgy

NLRP3 MODULATORS

#3 | 2023-06-29

US20230201143A1

Human necessities

METHODS OF TREATMENT

#4 | 2023-03-30

US20230102999A1

Chemistry; metallurgy

DEUTERATED NICLOSAMIDE

#5 | 2023-02-16

US20230049822A1

Human necessities

COMPOSITIONS COMPRISING NICLOSAMIDE FOR USE IN TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSE

#6 | 2022-09-15

US20220289736A1

Chemistry; metallurgy

NLRP3 modulators

#7 | 2022-04-07

US20220105057A1

Human necessities

Methods of treatment

#8 | 2022-03-17

US20220079897A1

Human necessities

Methods of treatment

#9 | 2022-01-06

US20220000812A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES

#10 | 2021-12-30

US20210401784A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#11 | 2020-09-03

US20200276140A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES

#12 | 2020-08-27

US20200268694A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#13 | 2020-06-25

US20200197340A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#14 | 2020-06-25

US20200197339A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#15 | 2020-05-21

US20200157097A1

Chemistry; metallurgy

NLRP3 modulators

#16 | 2020-05-21

US20200157096A1

Chemistry; metallurgy

NLRP3 MODULATORS

#17 | 2020-05-14

US20200147013A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory responses

#18 | 2020-05-14

US20200147012A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory responses

#19 | 2019-11-14

US20190345191A1

Chemistry; metallurgy

CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH STING (STIMULATOR OF INTERFERON GENES) ACTIVITY

#20 | 2019-10-03

US20190298670A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory response

#21 | 2019-05-02

US20190127368A1

Chemistry; metallurgy

NLRP3 modulators

#22 | 2019-05-02

US20190127367A1

Chemistry; metallurgy

NLRP3 modulators

#23 | 2019-02-28

US20190064146A1

Physics

IMMUNE CELLS HAVING INCREASED IMMUNITY OR RESISTANCE TO AN IMMUNOSUPPRESSIVE CYTOKINE AND USE OF THE SAME

#24 | 2018-11-22

US20180334438A1

Chemistry; metallurgy

PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

#25 | 2017-09-21

US20170267643A1

Chemistry; metallurgy

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#26 | 2017-03-02

US20170056448A1

Human necessities

IMMUNE CELLS HAVING INCREASED IMMUNITY OR RESISTANCE TO AN IMMUNOSUPPRESSIVE CYTOKINE AND USE OF THE SAME

#27 | 2017-03-02

US20170056347A1

Human necessities

Methods and compositions for treating conditions associated with an abnormal inflammatory responses

#28 | 2017-01-12

US20170007686A1

Human necessities

Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods

#29 | 2016-04-07

US20160095866A1

Human necessities

1,4-benzodiazepone-2,5-diones and related compounds with therapeutic properties

#30 | 2016-02-11

US20160039769A1

Chemistry; metallurgy

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#31 | 2015-11-26

US20150335625A1

Human necessities

Pyridonyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#32 | 2015-01-29

US20150031068A1

Physics

METHODS AND COMPOSITIONS FOR DETECTING IMMUNE SYSTEM ACTIVATION

#33 | 2014-03-27

US20140088094A1

Chemistry; metallurgy

N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

#34 | 2014-02-20

US20140051727A1

Chemistry; metallurgy

Pyridonyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#35 | 2014-02-06

US20140038947A1

Chemistry; metallurgy

Therapeutic applications of pro-apoptotic benzodiazepines

#36 | 2013-12-05

US20130324536A1

Chemistry; metallurgy

Pyrazolyl guanidine FF-atpase inhibitors and therapeutic uses thereof

#37 | 2013-10-17

US20130274197A1

Chemistry; metallurgy

Benzodiazepinone compounds useful in the treatment of skin conditions

#38 | 2013-10-03

US20130261110A1

Chemistry; metallurgy

1,4-benzodiazepine-2,5-diones with therapeutic properties

#39 | 2013-07-25

US20130190300A1

Chemistry; metallurgy

Compositions and methods for inhibiting the proliferation of cells

#40 | 2012-11-15

US20120289498A1

Chemistry; metallurgy

Compositions And Methods Relating To Novel Compounds And Targets Thereof

#41 | 2012-11-08

US20120283229A1

Human necessities

1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

#42 | 2012-10-25

US20120270862A1

Chemistry; metallurgy

1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

#43 | 2012-09-13

US20120232067A1

Chemistry; metallurgy

Benzodiazepinone compounds and methods of treatment using same

#44 | 2012-08-23

US20120214801A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF

#45 | 2012-06-28

US20120165301A1

Human necessities

BENZODIAZEPINE COMPOSITIONS FOR TREATING EPIDERMAL HYPERPLASIA AND RELATED DISORDERS

#46 | 2012-04-19

US20120094982A1

Chemistry; metallurgy

1,4-benzodiazepinone compounds and their use in treating cancer

#47 | 2012-04-12

US20120088757A1

Chemistry; metallurgy

NOVEL 1,4-BENZODIAZEPINE-2,5-DIONES WITH THERAPEUTIC PROPERTIES

#48 | 2012-03-29

US20120077805A1

Chemistry; metallurgy

UNSOLVATED BENZODIAZEPINE COMPOSITIONS AND METHODS

#49 | 2012-02-16

US20120040971A1

Chemistry; metallurgy

Benzodiazepinone compounds useful in the treatment of skin conditions

#50 | 2011-10-13

US20110251200A1

Human necessities

Aryl guanidine FF-ATPase inhibitors and related methods

#51 | 2011-08-11

US20110195959A1

Chemistry; metallurgy

Compositions and methods relating to novel compounds and targets thereof

#52 | 2010-09-02

US20100222400A1

Chemistry; metallurgy

FF-ATPase inhibitors and related methods

#53 | 2010-09-02

US20100222310A1

Human necessities

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#54 | 2010-01-07

US20100004227A1

Chemistry; metallurgy

Compositions and methods relating to novel compounds and targets thereof

#55 | 2009-11-05

US20090275099A1

Human necessities

Methods and compositions for treating diseases and conditions associated with mitochondrial function

#56 | 2009-10-08

US20090253686A1

Chemistry; metallurgy

Unsolvated benzodiazepine compositions and methods

#57 | 2009-08-13

US20090203734A1

Physics

F1F0-ATPASE INHIBITORS AND RELATED METHODS

#58 | 2009-05-07

US20090118244A1

Chemistry; metallurgy

Benzodiazepinone compounds useful in the treatment of skin conditions

#59 | 2009-01-08

US20090012065A1

Chemistry; metallurgy

Therapeutic applications of pro-apoptotic benzodiazepines

#60 | 2008-11-27

US20080293700A1

Human necessities

Compositions and Methods Relating to Novel Compounds and Targets Thereof

#61 | 2008-10-30

US20080269203A1

Human necessities

Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

#62 | 2008-10-30

US20080269194A1

Chemistry; metallurgy

Compositions and methods relating to novel compounds and targets thereof

#63 | 2007-12-27

US20070299059A1

Chemistry; metallurgy

Compostions and methods relating to novel compounds and targets thereof

#64 | 2007-10-02

US10795535

Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof

#65 | 2007-06-14

US20070135418A1

Chemistry; metallurgy

Compositions and methods for inhibiting the proliferation of cells

#66 | 2007-05-22

US9767283

Therapeutic application of pro-apoptotic benzodiazepines

#67 | 2007-05-17

US20070111994A1

Chemistry; metallurgy

1,4-benzodiazepine-2,5-diones with therapeutic properties

#68 | 2007-05-10

US20070105844A1

Human necessities

Therapeutic compositions and methods

#69 | 2007-02-22

US20070043033A1

Chemistry; metallurgy

Unsolvated benzodiazepine compositions and methods

#70 | 2007-02-15

US20070036854A1

Chemistry; metallurgy

Therapeutic applications of pro-apoptotic benzodiazepines

#71 | 2006-12-05

US10427212

Compositions relating to novel compounds and targets thereof

#72 | 2006-10-24

US9700101

Therapeutic applications of pro-apoptotic benzodiazepines

#73 | 2006-07-27

US20060166975A1

Human necessities

Compositions and methods relating to novel benzodiazepine compounds and derivatives

#74 | 2006-03-09

US20060052369A1

Human necessities

Compositions and methods relating to novel compounds and targets thereof

#75 | 2006-02-02

US20060025388A1

Human necessities

Compositions and methods relating to novel compounds and targets thereof

#76 | 2005-12-08

US20050272723A1

Human necessities

Methods and compositions for treating diseases and conditions associated with mitochondrial function

#77 | 2005-11-24

US20050261176A1

Chemistry; metallurgy

Compositions and methods relating to novel compounds and targets thereof

#78 | 2005-05-26

US20050113460A1

Human necessities

Compositions and methods relating to novel compounds and targets thereof

InventorID:

355613 ⎘